Vertex Pharmaceuticals Incorporated Investors: [email protected] Susie Lisa, CFA: +1 617-341-6108 or Miroslava Minkova: +1 617-341-6135 Media: [email protected] or International: +44 20 3204 ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a listen-only mode. [Operator instructions] Please note, this event is being ...
Hosted on MSN14d
Vertex Pharmaceuticals (VRTX) Q4 2024 Earnings Call TranscriptLearn more here. Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a listen-only mode. [Operator instructions] Please note ...
Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter 2024 Earnings Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation ...
Railway Recruitment Boards has extended the registration date for RRB Ministerial & Isolated Categories Recruitment 2025. The last date to apply has been extended till February 16, 2025.
Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating ...
Copyright 2025 The Associated Press. All Rights Reserved. Two pedestrians walk on the campus of Tufts University, Friday Jan. 31, 2025 in Medford, Mass., where an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback